Closer to Autograft Than Ever Before.

OSTEOAMP has been shown to retain up to 23 natural growth factors that support bone formation.1

See clinical dataBioventus Arrow Down

OSTEOAMP is backed by science to meet the surgeon's need for a proven allograft that can achieve solid fusion outcomes.

Recent studies show that OSTEOAMP, as a result of our proprietary method of processing bone and bone marrow, has been shown to retain up to 23 growth factors at each phase of the natural bone healing process.1

The OSTEOAMP Difference

  • Our proprietary method of processing bone and bone marrow makes OSTEOAMP different from demineralized bone matrix (DBM) products that strip away bone marrow during processing, which reduces their potential for initiating osteoinduction and angiogenesis.
  • Peer-reviewed publications report that OSTEOAMP is a viable alternative to Infuse®, based on fusion rates and time to fusion in lumbar spine fusion.2


  • OSTEOAMP has been shown to be 73.7% less expensive per level than Infuse in one published study where 321 patients were evaluated in a TLIF/LLIF approach.2


  • Donor bone is sourced from AATB-certified and FDA-registered tissue banks in the United States.
  • All tissues are screened for the standard panel of infectious viruses.
  • Manufacturing and sterilization processes have been validated to inactivate HIV-1, Bovine Herpes Virus (BHV), Bovine Viral Diarrhea Virus (BVDV), Hepatitis A Virus (HAV) and Porcine Parvovirus (PPV).

Three formats to meet the unique needs of your patient


OSTEOAMP granules combine osteoconductive and osteoinductive properties with mineralized cortical-cancellous allograft chips.


All formats may be rehydrated with bone marrow aspirate, blood, or saline. For optimal handling of the putty, bone marrow aspirate or blood are recommended.


Combines both osteoconductive and osteoinductive properties in an easy-to-use compressible sponge. The malleable implant readily conforms to various interbody devices and/or bony defects.

Published literature supports the use of OSTEOAMP in both cervical and lumbar spine fusion procedures, and published evidence reports that OSTEOAMP achieves solid bone fusion in less time than Infuse.2

Cervical Fusion

Fusion rates of 97.6% at 12 months and 100% at 18 months when OSTEOAMP was used, exceed fusion rates reported in the literature for traditional DBMs.3

Lumbar Interbody Fusion

A higher percentage of patients achieved fusion in the OSTEOAMP group at all time points than the in the rhBPM-2 group (p<0.01). Total time for fusion for OSTEOAMP was approximately 40% shorter than that of rhBPM-2 (207.9 and 333.9 days, respectively).2

Clinical Evidence

OSTEOAMP Foot and Ankle Arthrodesis – DeVries et al.

OSTEOAMP vs. Infuse® Lumbar Interbody Fusion Retrospective - Roh et al.

OSTEOAMP Cervical Fusion Retrospective - Field et al.

OSTEOAMP Clinical Efficacy Validation - Yeung et al.

Let us know how we can help

To request more information on OSTEOAMP or to contact your local Bioventus Surgical representative to order, please fill out this form.

Instructions For Use
OSTEOAMP – DCI Doner Services Tissue Bank
OSTEOAMP – Lifelink Tissue Bank
OSTEOAMP – Pinnacle Transplant Technologies

Material Management Packet
OSTEOAMP – Material Management Packet


Request more information

  • This field is for validation purposes and should be left unchanged.